Northern Trust Corp Y M Abs Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 337,287 shares of YMAB stock, worth $2.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

337,287

Previous 317,805 6.13%

Holding current value

$2.75 Million

Previous $3.84 Million 15.34%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$9.95 - $15.39 $193,845 - $299,827	19,482 Added 6.13%	337,287 $4.43 Million
Q2 2024 Aug 14, 2024	SELL	$11.6 - $17.25 $45,356 - $67,447	-3,910 Reduced 1.22%	317,805 $3.84 Million
Q1 2024 May 14, 2024	SELL	$6.57 - $18.69 $24,466 - $69,601	-3,724 Reduced 1.14%	321,715 $5.23 Million
Q4 2023 Feb 13, 2024	BUY	$4.88 - $7.42 $10,989 - $16,709	2,252 Added 0.7%	325,439 $2.22 Million
Q3 2023 Nov 13, 2023	SELL	$4.86 - $7.23 $25,928 - $38,572	-5,335 Reduced 1.62%	323,187 $1.76 Million
Q2 2023 Aug 11, 2023	BUY	$5.68 - $10.34 $148,776 - $270,835	26,193 Added 8.66%	328,522 $2.23 Million
Q1 2023 May 15, 2023	SELL	$2.83 - $5.11 $51,172 - $92,399	-18,082 Reduced 5.64%	302,329 $1.51 Million
Q4 2022 Feb 13, 2023	SELL	$3.0 - $15.17 $25,836 - $130,644	-8,612 Reduced 2.62%	320,411 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $56,887 - $80,155	-4,075 Reduced 1.22%	329,023 $4.75 Million
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $48,045 - $88,434	5,845 Added 1.79%	333,098 $5.04 Million
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $109,607 - $291,506	-16,734 Reduced 4.86%	327,253 $3.89 Million
Q4 2021 Feb 08, 2022	SELL	$15.51 - $29.31 $47,258 - $89,307	-3,047 Reduced 0.88%	343,987 $5.58 Million
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $17,251 - $23,430	628 Added 0.18%	347,034 $9.9 Million
Q2 2021 Aug 13, 2021	BUY	$25.45 - $37.64 $15,397 - $22,772	605 Added 0.17%	346,406 $11.7 Million
Q1 2021 May 12, 2021	SELL	$29.16 - $51.96 $212,809 - $379,204	-7,298 Reduced 2.07%	345,801 $10.5 Million
Q4 2020 Feb 11, 2021	SELL	$37.86 - $54.26 $798,732 - $1.14 Million	-21,097 Reduced 5.64%	353,099 $17.5 Million
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $177,757 - $220,717	-5,060 Reduced 1.33%	374,196 $14.4 Million
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $1.96 Million - $4.1 Million	82,770 Added 27.92%	379,256 $16.4 Million
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $109,191 - $271,650	7,588 Added 2.63%	296,486 $7.74 Million
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $989,829 - $1.4 Million	41,572 Added 16.81%	288,898 $9.03 Million
Q3 2019 Nov 13, 2019	BUY	$21.57 - $31.37 $2.88 Million - $4.18 Million	133,303 Added 116.91%	247,326 $6.45 Million
Q2 2019 Aug 13, 2019	BUY	$19.51 - $28.31 $634,679 - $920,952	32,531 Added 39.92%	114,023 $2.61 Million
Q1 2019 May 13, 2019	BUY	$18.21 - $26.21 $112,228 - $161,532	6,163 Added 8.18%	81,492 $2.14 Million
Q4 2018 Feb 12, 2019	BUY	$15.41 - $28.92 $1.16 Million - $2.18 Million	75,329 New	75,329 $1.53 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Y M Abs Therapeutics, Inc. Transaction History